𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis

✍ Scribed by C. Ryan; L. Renfro; P. Collins; B. Kirby; S. Rogers


Book ID
108671398
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
193 KB
Volume
163
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A randomized, observer-blinded trial of
✍ H. Cameron; R.S. Dawe; S. Yule; J. Murphy; S.H. Ibbotson; J. Ferguson πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 218 KB

## Background: The optimum treatment frequency for narrowband (tl-01) ultraviolet b (nb-uvb) in psoriasis is not yet known. we have previously found three times weekly to be preferable to five times weekly treatment in our population. ## Objectives: To compare twice weekly with three times weekly

Rationale for use and clinical responsiv
✍ C. Durakovic; A. Malabanan; M.F. Holick πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 516 KB

## Background: Vitamin d analogues are useful in topical therapy of psoriasis. ## Objectives: To evaluate the effect of hexafluoro-1,25-dihydroxyvitamin d3 (f6-1,25(oh)2d3) in treatment of psoriasis. ## Methods: Fifteen patients with plaque-type psoriasis were enrolled in a single centre double

Calcitriol 3 Β΅g gβˆ’1 ointment in combinat
✍ J. Ring; L. Kowalzick; E. Christophers; W.B. Schill; E. SchΓΆpf; M. StΓ€nder; H.H. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 264 KB

## Background: Combinations of topical treatments and ultraviolet (uv) b phototherapy for plaque psoriasis may be more beneficial than either type of treatment used alone. ## Objectives: To determine the efficacy of calcitriol 3 microg g-1 ointment in combination with uvb phototherapy in treating

Predictors of response of U.S. veterans
✍ Lisa I. Backus; Derek B. Boothroyd; Barbara R. Phillips; Larry A. Mole πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

The currently recommended treatment for hepatitis C virus (HCV) infection is pegylated interferon alfa (PEG-INF) and ribavirin, which can be difficult to tolerate. More information about predicting sustained virologic response (SVR) may allow more informed treatment decisions to be made. This retros